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Febrile illness often presents a challenge for the clinician.
The main causes of febrile illness are infections, solid or
haematological malignancies and connective tissue
disorders, including vasculitis. A 49-year-old woman
sought medical attention because of intermittent fever
that lasted 2 weeks. She presented no further symptoms
or physical signs to suggest the aetiology. The
epidemiological context was irrelevant. Analyses revealed
anaemia of chronic disease and signiﬁcant elevations of
inﬂammatory parameters. A comprehensive study was
performed, which revealed presence of an aortitis.
Investigation of infectious and immunological causes was
negative. We arrived at the deﬁnitive diagnosis of
isolated aortitis. She was treated with corticosteroid and
methotrexate, with resolution of symptoms and clinical
abnormalities.
BACKGROUND
Fever is a common reason for seeking medical care.
Usually, the cause is easily identiﬁable with patient
observation, but in a minority of cases, it represents
a clinical challenge.1 2 Possible causes of febrile
illness are multiple. The most frequent are infec-
tions, solid or haematological malignancies and
conjunctive tissue diseases,1 2 including vasculitis.
Vasculitis can manifest with symptoms related to
local vascular inﬂammation, or simply with fever and
constitutional symptoms.3 Therefore, their diagnosis
is dependent on careful clinical suspicion. The aorta
can be affected by the inﬂammatory process in the
course of a large vessel vasculitis, and in some cases,
this can be the only location of disease. The most
important diagnoses to consider are Takayasu’s arter-
itis (TA) and giant cell arteritis (GCA).3
We present a case of isolated aortitis that mani-
fested with fever in a patient who presents no
further symptoms or diagnostic criteria for TA or
GCA.
CASE PRESENTATION
A 49-year-old woman sought medical attention
because of intermittent fever that lasted 2 weeks.
She had no respiratory, neurological, gastrointes-
tinal or urinary symptoms, and also denied arthralgia.
She had a history of transient malar rash and
gastro-oesophageal reﬂux treated with omeprazole.
She lived in an urban area and worked in an
ofﬁce. She denied recent travel, animal contact or
consumption of unpasteurised products. She had
no signiﬁcant family history.
On examination, she presented a good general
condition; she was eupnoeic and normotensive.
She had no localised signs of infection, such as
nuchal rigidity, alterations in cardiopulmonary
auscultation or in abdominal palpation, and no
costovertebral angle tenderness or
lymphadenopathy.
Laboratory tests showed normocytic anaemia
(haemoglobin (Hb) 9.6 g/dL, mean corpuscular
volume 79.9 fL), increased inﬂammatory para-
meters with 12 200 leucocytes/mL with normal
formula and sedimentation rate of 120 mm/h, C
reactive protein (CRP) 196.8 mg/L. Renal function,
coagulation, hepatic enzymology, lactate dehydro-
genase and summary urine analyses were normal
(table 1). Chest radiograph showed no pulmonary
or mediastinal changes.
INVESTIGATIONS
Blood cultures and urine culture were sterile.
Serologies for HIV infection (fourth generation
test), hepatitis virus, Coxiella and Brucella were
also negative. Investigation of anaemia revealed
normal ferritin, no vitamin deﬁcits, normal thyroid
function and negative Coombs’ test.
A transthoracic echocardiogram revealed no signs
of endocarditis or valvular disease.
As there was no evidence of infection after the
ﬁrst stage of investigation, we directed our study to
possible immunological and neoplastic causes.
The patient had positive antinuclear antibody
(ANA; 1/160, granular pattern) without speciﬁcity
in an ELISA study, without complement consump-
tion, negative antidouble stranded DNA, negative
antiphospholipid antibodies, negative antineutro-
phil cytoplasmic antibody or negative rheumatoid
factor. Electrophoresis of protein was normal and
there was no proteinuria in 24 h urine collection.
CT of the thorax and abdomen was performed,
which excluded the presence of abnormal lymph
nodes or other signs of lymphoproliferative disease
or tuberculosis. Since of an abnormally thickened
aortic wall, the study was complemented with
angio-CT, conﬁrming regular concentric wall thick-
ening of the entire aorta, from the aortic valve to
the iliac bifurcation (ﬁgure 1). There was no
involvement of the major branches of the aorta,
and no stenosis or aneurysmal dilatations. These
ﬁndings were suggestive of aortitis.
DIFFERENTIAL DIAGNOSIS
The differential diagnoses of isolated aortitis
include infectious and autoimmune aetiologies.3–5
Infectious aetiologies include acute bacterial infec-
tions, syphilis, tuberculosis and HIV infections.3 6
Autoimmune aetiologies include large vessel vascu-
litis, such as TA, GCA and Behçet’s disease.3 7
Acute bacterial infection and HIV were excluded
by the earlier examinations. Imaging studies did
not ﬁnd any sign of tuberculosis, and blood culture
Fior A, Barreto P. BMJ Case Rep 2015. doi:10.1136/bcr-2014-209271 1
Reminder of important clinical lesson
directed to mycobacteria was negative (BACTEC system).
Venereal Disease Research Laboratory test was negative.
Behçet’s disease was not probable without other signs of
disease such as arthralgia, skin lesions, oral–genital ulcerations
or uveitis.
We checked for other signs of large vessel vasculitis but the
patient had no tenderness or thickening in temporal arteries or
changes of peripheral pulses. Carotid and vertebral Doppler
were normal. Retinal disease was excluded by ophthalmological
examination.
We arrived at the deﬁnitive diagnosis of isolated (idiopathic)
aortitis; the patient presented no further symptoms or diagnos-
tic criteria suggestive of TA or GCA; it is remarkable that her
age was intermediate between the typical age presentations of
these two entities.
Biopsy was not performed because there was no involvement
of peripheral vessels. It was not possible to perform a ﬂuoro-
deoxyglucose positron emission tomography before beginning
treatment.
TREATMENT
The patient began treatment with prednisolone 1 mg/kg/day
with good clinical and laboratory response. Fever and malaise
disappeared in the ﬁrst 48 h and laboratory abnormalities nor-
malised in 2 weeks. Methotrexate 15 mg/week was added as cor-
ticoid sparing agent and corticosteroids were tapered
progressively.
OUTCOME AND FOLLOW-UP
After 6 months of treatment, the patient is taking 7.5 mg/day of
prednisolone and continues methotrexate. She has no symptoms
and blood tests are normal, with Hb 13 g/dL, sedimentation rate
13 mm/h and CRP 2.0 mg/L.
Unfortunately, the patient experienced adverse effects from
corticosteroids, including weight gain, hypertrichosis and
anxiety.
DISCUSSION
Febrile illness can be a challenging clinical situation and, in rare
cases, data from clinical history, physical examination and blood
tests is not sufﬁcient for diagnosis. In this particular case, CT
scan was key in establishing the diagnosis.
Aortitis is an inﬂammation of the aortic wall and may have
various causes, including infectious and non-infectious.3–5
When it is caused by common bacteria such as Staphylococcus
or Salmonella, it is said to be pyogenic, and courses with acute
septic disease and positive blood cultures.6 There are more
insidious infectious causes, such as tuberculosis, syphilis or
HIV,3 6 all excluded during the investigation.
Within the inﬂammatory causes, we should consider vasculitis
of large vessels, such as TA, GCA and Behçet’s disease.3 7 The
patient did not present symptoms or diagnostic criteria suggest-
ive of systemic lupus erythematosus.
Behçet’s disease is associated with vasculitis in vessels of
various sizes, including the aorta.8 Diagnosis is based on the
classical clinical signs such as oral–genital ulceration, uveitis,
arthralgia and cutaneous lesions,8 which were absent in this
case.
TA is a rare disease primarily affecting women in the second
and third decades of life.9 10 It is a panarteritis that affects the
aorta and its branches, as well as the pulmonary artery.10
Chronic inﬂammation induces ﬁbrosis and vascular fragility,
with consequent development of stenosis or aneurysm.10 It
manifests as constitutional symptoms of systemic inﬂammation
and by local vascular complications such as ischaemia or aneur-
ysm rupture.10
GCA affects older ages, typically during the seventh and eigth
decades of life.3 It often affects the branches of the external
carotid artery, including the ophthalmic artery. It is generally
associated with osteomuscular pain (polymyalgia rheumatica).3
It can be associated with vasculitis of the aorta and its branches,
manifesting similarly to TA.3
No speciﬁc serological tests exist for TA and GCA,9–11 render-
ing deﬁnitive diagnosis difﬁcult. The diagnosis is based on sug-
gestive clinical ﬁndings and imaging tests.9–11 When there is
disease in superﬁcial vessels, a biopsy can conﬁrm the diagnosis.
The American College of Rheumatology established classiﬁca-
tion criteria for both diseases in 1990 (box 1).
Figure 1 Angio-CT of the aorta, coronal (left) and transversal (right)
view: thoracic and abdominal aorta with regular continuous concentric
thickening of the vascular wall (white arrows).
Table 1 Baseline laboratory values
Haemoglobin (11.5–15.5×10 g/L) 9.6








Sedimentation rate (<20 mm/h) 120
C reactive protein (<5.0 mg/L) 196.8
Urea (15.0–40.0 mg/dL) 22
Creatinine (0.51–0.95 mg/dL) 0.80
Sodium (136–145 mEq/L) 139
Potassium (3.50–5.10 mEq/L) 4.1
Chlorine (98–106 mEq/L) 99
Calcium (8.8–10.8 mg/dL) 9.8
Proteins (66–83 g/L) 84.6
Albumin (35–52 g/L) 37.0
Bilirubin (0.3–1.2 mg/dL) 0.44
Aspartate aminotransferase (<35 U/L) 17
Alanine aminotransferase (<35 U/L) 16
Creatine kinase (<145 U/L) 60
Iron (60–180 μg/dL) 12
Lactate dehydrogenase (<247 U/L) 182
Ferritin (11–307 ng/mL) 160
Transferrin (2.00–3.60 g/L) 1.93
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Angiography is considered the gold standard diagnostic test;
however, it only shows changes of the vascular lumen but not of
the vessel wall and, therefore, gives little information regarding
activity of disease.3–5 Current CT and MR equipment permit
observation of the thickness of the vascular wall, which is a
marker of inﬂammation, and therefore has greater diagnostic
accuracy with less risk.3–5
The recently described IgG4-related disease has been asso-
ciated with aortitis. This ﬁnding comes from reports of operated
aortas with unexpected inﬁltration of lymphocytes and plasma
cells with histological characteristics typical of this disease.12
Unlike this case, in IgG4-related disease there is no signiﬁcant
systemic inﬂammatory response.
Isolated aortitis can be the sole or initial manifestation of a
large vessel vasculitis such as TA or GCA.13 Cases of isolated
aortitis without other vascular lesions are described in the litera-
ture.13–15 Most are diagnosed incidentally or after a complica-
tion, for example, an aortic aneurysm.14–16 These entities do
not normally manifest systemic symptoms, they can be benign
with generally good outcomes, despite the absence of anti-
inﬂammatory therapy.14 15 Indications for treatment in this situ-
ation is controversial.14 17 In our case, systemic manifestation
predominates the clinical picture, which suggests an active
inﬂammatory disease and an insidious process, typical of TA or
CGA. For this reason we decided to start systemic immunosup-
pressor treatment.
Regarding treatment, TA and GCA have similar approaches.
Since the amount of observational studies and clinical trials is
limited, treatment is based mainly on expert experience.18
The ﬁrst-line treatment is systemic corticosteroids in a dose of
1 mg/kg/day of prednisone (or equivalent).3 10 18 In severe
cases, cyclophosphamide is used.10 18
Corticosteroids should be progressively weaned to doses
below 10 mg/day after approximately 3 months.18 The disease
tends to evolve by ﬂares, and therefore some experts suggest
adding an immunosuppressor to reduce the cumulative dose of
corticosteroids. The most commonly used immunosuppressants
are methotrexate and azathioprine.10 18
Some cases of refractory disease responsive to novel biotech-
nological drugs have been reported, especially using tocilizumab
(anti-interleukin 6).19–21
Monitoring of large vessel vasculitis is another controversial
issue since there are no validated activity scores.10 Clinical signs
and routine inﬂammatory markers, although useful, are not suf-
ﬁciently good indicators of vascular inﬂammation, since it is
demonstrated that vasculitis may remain active even after nor-
malisation of inﬂammatory parameters.10
Learning points
▸ Persistent fever alone can be the manifestation of an occult
severe disease.
▸ Knowledge about rare diseases facilitates the diagnosis in
subtle cases.
▸ Development of imaging technology has improved diagnosis
accuracy, especially when the clinical signs are insufﬁcient.
▸ Isolated aortitis may be the sole manifestation of large
vessel vasculitis such as Takayasu’s arteritis or giant cell
arteritis.
Competing interests None declared.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.
REFERENCES
1 Varghese GM, Trowbridge P, Doherty T. Investigating and managing pyrexia of
unknown origin in adults. BMJ 2010;341:C5470.
2 Carmoi T, Grateau G, Billhot M, et al. [Prolonged fever: speciﬁc issues in the young
adult population]. Rev Med Interne 2010;31:838–45.
3 Gornik HL, Creager MA. Aortitis. Circulation 2008;117:3039–51.
4 Katabathina VS, Restrepo CS. Infectious and noninfectious aortitis: cross-sectional
imaging ﬁndings. Semin Ultrasound CT MR 2012;33:207–21.
5 Restrepo CS, Ocazionez D, Suri R, et al. Aortitis: imaging spectrum of the infectious
and inﬂammatory conditions of the aorta. Radiographics 2011;31:435–51.
6 Lopes RJ, Almeida J, Dias PJ, et al. Infectious thoracic aortitis: a literature review.
Clin Cardiol 2009;32:488–90.
7 Launay D, Hachulla E. [Inﬂammatory aortitis]. Presse Med 2004;33(19 Pt 1):1334–40.
8 Sakane T, Takeno M, Suzuki N, et al. Behçet’s disease. N Engl J Med
1999;341:1284–91.
9 Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990
criteria for the classiﬁcation of Takayasu arteritis. Arthritis Rheum 1990;33:1129–34.
10 Isobe M. Takayasu arteritis revisited: current diagnosis and treatment. Int J Cardiol
2013;168:3–10.
11 Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology
1990 criteria for the classiﬁcation of giant cell arteritis. Arthritis Rheum
1990;33:1122–8.
12 Stone JH, Khosroshahi A, Deshpande V, et al. IgG4-related systemic disease
accounts for a signiﬁcant proportion of thoracic lymphoplasmacytic aortitis cases.
Arthritis Care Res (Hoboken) 2010;62:316–22.
13 Talarico R, Boiardi L, Pipitone N, et al. Isolated aortitis versus giant cell arteritis: are
they really two sides of the same coin? Clin Exp Rheumatol 2014;32(3 Suppl 82):
S55–8.
14 Rojo-Leyva F, Ratliff NB, Cosgrove DM III, et al. Study of 52 patients with idiopathic
aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum 2000;43:901–7.
15 Schmidt J, Sunesen K, Kornum JB, et al. Predictors for pathologically conﬁrmed
aortitis after resection of the ascending aorta: a 12-year Danish nationwide
population-based cross-sectional study. Arthritis Res Ther 2011;13:R87.
16 Liang KP, Chowdhary VR, Michet CJ, et al. Noninfectious ascending aortitis: a case
series of 64 patients. J Rheumatol 2009;36:2290–7.
17 Miller DV, Isotalo PA, Weyand CM, et al. Surgical pathology of noninfectious
ascending aortitis: a study of 45 cases with emphasis on an isolated variant. Am J
Surg Pathol 2006;30:1150–8.
Box 1 Criteria for the classiﬁcation of large vessel
vasculitis, American College of Rheumatology in 19909 11
Criteria for the classiﬁcation of Takayasu arteritis*
1. Age at disease onset <40 years
2. Claudication of extremities
3. Decreased brachial artery pulse
4. Difference of >10 mm Hg in systolic blood pressure between
arms
5. Bruit over subclavian arteries or aorta
6. Arteriogram abnormality (narrowing or occlusion of the
entire aorta, its primary branches or large arteries in the
proximal upper or lower extremities)
Criteria for the classiﬁcation of giant cell (temporal) arteritis†
1. Age at disease onset ≥50 years
2. New headache
3. Temporal artery tenderness to palpation or decreased
pulsation
4. Elevated erythrocyte sedimentation rate
5. Abnormal artery biopsy (vasculitis characterised by a
predominance of mononuclear cell inﬁltration or
granulomatous inﬂammation, usually with multinucleated
giant cells)
* 3 of 6 criteria are needed for classiﬁcation as Takayasu
arteritis
† 3 of 5 criteria are needed for classiﬁcation as giant cell
arteritis
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